The latest approval adds another generic option to the market, but it's not expected to change access in states where abortion is still restricted or banned. HealthDay News — A new low-cost version of ...
The US Food and Drug Administration (FDA) has approved a supplemental Abbreviated New Drug Application (sNDA) sponsored by Par Pharmaceuticals for a 300 mg, extended-release version of the popular ...
Beam stock launched to a 10-month high Monday after the company reached a deal with the Food and Drug Administration for its gene-editing drug, BEAM-302. Beam TherapeuticsBEAM is testing its drug in ...
Aug. 27 (UPI) --The federal government signed-off on the latest round of COVID-19 vaccines, but new limits were set on which Americans can get them after U.S. Health and Human Services Secretary ...
The Trump administration is cracking down on pharmaceutical ads that target consumers directly. Senior officials say enforcement of existing regulations has been lax. They want to change that. NPR ...